Related references
Note: Only part of the references are listed.A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes
Angelique W. Levi et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows
Cornelis Johannes Jacobus Huijsmans et al.
BMC CANCER (2016)
Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities
D. Fornari et al.
CYTOPATHOLOGY (2016)
Ten years of R&D and full automation in molecular diagnosis
Gilbert Greub et al.
FUTURE MICROBIOLOGY (2016)
Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
Darrel A. Cook et al.
BMC CANCER (2015)
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M. Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework
K. Cuschieri et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Comparing the performance of six human papillomavirus tests in a screening population
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2013)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Validation of high-risk HPV tests for primary cervical screening
C. J. L. M. Meijer et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
N. W. J. Bulkmans et al.
LANCET (2007)
Share Paper
